GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » Cyclically Adjusted Revenue per Share

Kee Song Bio-Technology Holdings (ROCO:1258) Cyclically Adjusted Revenue per Share : NT$72.99 (As of Mar. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Kee Song Bio-Technology Holdings's adjusted revenue per share for the three months ended in Mar. 2023 was NT$19.932. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$72.99 for the trailing ten years ended in Mar. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-21), Kee Song Bio-Technology Holdings's current stock price is NT$26.85. Kee Song Bio-Technology Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 was NT$72.99. Kee Song Bio-Technology Holdings's Cyclically Adjusted PS Ratio of today is 0.37.


Kee Song Bio-Technology Holdings Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings Cyclically Adjusted Revenue per Share Chart

Kee Song Bio-Technology Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 62.27 65.31 71.03

Kee Song Bio-Technology Holdings Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.31 69.91 70.33 71.03 72.99

Competitive Comparison of Kee Song Bio-Technology Holdings's Cyclically Adjusted Revenue per Share

For the Packaged Foods subindustry, Kee Song Bio-Technology Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kee Song Bio-Technology Holdings's Cyclically Adjusted PS Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kee Song Bio-Technology Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kee Song Bio-Technology Holdings's Cyclically Adjusted PS Ratio falls into.



Kee Song Bio-Technology Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kee Song Bio-Technology Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=19.932/127.3478*127.3478
=19.932

Current CPI (Mar. 2023) = 127.3478.

Kee Song Bio-Technology Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201306 8.719 98.518 11.271
201309 9.487 98.790 12.229
201312 9.228 98.326 11.952
201403 9.692 99.695 12.380
201406 9.257 100.560 11.723
201409 9.905 100.428 12.560
201412 9.812 99.070 12.613
201503 9.535 99.621 12.189
201506 12.566 100.684 15.894
201509 16.085 100.392 20.404
201512 13.006 99.792 16.597
201603 15.312 100.470 19.408
201606 15.519 101.688 19.435
201609 16.481 101.861 20.605
201612 14.584 101.863 18.233
201703 14.901 102.862 18.448
201706 15.709 103.349 19.357
201709 17.964 104.136 21.968
201712 14.883 104.011 18.222
201803 18.408 105.290 22.265
201806 20.009 106.317 23.967
201809 19.164 106.507 22.914
201812 19.530 105.998 23.464
201903 21.257 107.251 25.240
201906 18.988 108.070 22.375
201909 22.170 108.329 26.062
201912 20.473 108.420 24.047
202003 19.584 108.902 22.901
202006 17.082 108.767 20.000
202009 16.704 109.815 19.371
202012 15.688 109.897 18.179
202103 12.332 111.754 14.053
202106 13.040 114.631 14.487
202109 14.548 115.734 16.008
202112 16.292 117.630 17.638
202203 16.469 121.301 17.290
202206 17.691 125.017 18.021
202209 15.911 125.227 16.181
202212 19.679 125.222 20.013
202303 19.932 127.348 19.932

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Kee Song Bio-Technology Holdings  (ROCO:1258) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Kee Song Bio-Technology Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=26.85/72.99
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Kee Song Bio-Technology Holdings Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Traded in Other Exchanges
N/A
Address
Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104
Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines